Foundation for Promotion of Cardiology / стр. 22 из 30

Main news

Dear colleagues!

On August 28, 2026, the full texts of the new clinical guidelines were published on the official website of the European Society of Cardiology (ESC), dedicated to the issues of cardiovascular diseases and chronic kidney disease.

The provisions of these clinical recommendations were presented to the participants of a number of specially organized scientific sessions, and also served as a reason for active discussions.

Press release

International Research in Cardiology 2010-2014 Dear colleagues!
The Cardioprogress Foundation presents the book «International Research in Cardiology», which includes the results of the most important international clinical trials presented in 2010-2024. The authors systematized studies in 21 sections, which include risk factors, antiplatelet and anticoagulant therapy, laboratory and instrumental diagnostics, arrhythmia, invasive cardiology, valvular heart diseases, intensive care in cardiology and more.

New Drug Combos Could Cut Heart Failure Mortality by 60% Optimized treatment can reduce the mortality risk for chronic heart failure (HF) by as much as 60%. The role of appropriate drug combinations and rapid diagnosis was discussed at the 91st Annual German Society of Cardiovascular Medicine Annual Conference.

Editorial Activity

cardiology book

X International forum of cardiology and internal medicine Dear Colleagues! The jubilee X International Forum of Cardiology and Internal medicine in the online format has completed. Event diaries, abstract book, forum report, and full versions of video recordings of lectures are presented at the links

Eating meat ‘raises risk of heart disease, diabetes and pneumonia UK researchers find link between regular meat intake and nine non-cancerous illnesses. Eating meat regularly increases a person’s risk of developing heart disease, diabetes, pneumonia and other serious illnesses, research has found.

COVID-19 Vaccination for Healthcare Workers. What You Need to Know As most of the world hopes for an end to the coronavirus disease 2019 (COVID-19) pandemic, trust in a vaccine provides a glimmer of hope. Limited quantities of 2 anti-COVID-19 vaccines are available in the United States, mandating prioritizing populations for vaccination. Healthcare workers (HCW) are key on the list, as they are on COVID-19 care front lines and are at high risk for exposure and transmission.

Current Overview on Hypercoagulability in COVID-19 The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as coagulopathy, prompting a desperate need for effective management. COVID-19-associated coagulopathy (CAC) can cause various thromboembolic complications, especially in critically ill patients.

ESC/EACTS to Review Left Main Revascularization Guidance Patrice Wendling The European Society of Cardiology and European Association for Cardiothoracic Surgery (ESC/EACTS) have announced they will review their joint recommendations for left main coronary artery disease in light of emerging data.

Russian National Congress of Cardiology 2020 CONFERENCE NEWS

World Heart Day On World Heart Day, 29 September 2020, we’re asking the world to Use Heart to beat CVD ... for your loved ones, society and you.

European Society of Cardiology (ESC) Congress 2020. CONFERENCE NEWS

Scientific news

Blood Pressure Variability Linked to Mortality in Patients With ANCA-Associated Vasculitis Among patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis undergoing maintenance therapy, greater visit-to-visit systolic blood pressure variability (SBPV) was independently associated with an increased risk for all-cause mortality.

Morphine Underused for End-of-Life Dyspnea in the Emergency Department Compared with Inpatient Care Among 250 patients presenting to the emergency department (ED) with dyspnea at the end of life, 15.2% received morphine in the ED, whereas 68% received it during subsequent inpatient care. Patients with lung cancer or a do-not-resuscitate order were more likely to receive morphine in the ED, but its use was not associated with reduced survival.

Present state and future of screening for atrial fibrillation: a state-of-the-art review Atrial fibrillation is the most common arrhythmia and is a leading cause of stroke and heart failure yet often remains undiagnosed. Screening has been proposed to identify asymptomatic AF and initiate preventive treatment, but evidence for reduction in hard clinical endpoints such as stroke and heart failure remains inconclusive.

Levosimendan versus dobutamine in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials Acute decompensated heart failure with reduced ejection fraction often requires inotropic support. While dobutamine is commonly used, its safety and efficacy remain debated. Levosimendan has emerged as a potential alternative, with distinct pharmacological properties.

Cardiovascular Benefits of Semaglutide in SELECT Trial Not Fully Explained by Weight Loss and Other Improvements In adults with obesity and established cardiovascular disease (CVD), semaglutide was associated with improvements in several risk factors. However, those changes only accounted for part of the reduced risk for major adverse cardiovascular events (MACE) noted in the SELECT trial.

Partners

Video resource

Channel "Cardioprogress"

CARDIOPROGRESS
Foundation for the advancement of cardiology